window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : December 6, 2025

  • News
  • About Us
Contact Us

Neurosciences

  • Artificial Intelligence,Clinical studies,Digital Health,Medical devices,Neurosciences

    Neuraxpharm and mjn-neuro plan launch of digital solution for early detection of epileptic seizures

    Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

    December 3, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health,Neurosciences,Research & Development

    Linus Health to present AI-driven brain health research at CTAD 2025

    Linus Health, an AI-driven brain health company focused on early [...]

    November 20, 2025
  • Central Nervous System,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Porosome reconstitution therapy reverses Alzheimer’s pathology in human brain organoids

    Porosome Therapeutics has reported preclinical results showing that restoring porosome [...]

    November 18, 2025
  • Biotech,Clinical Development,Clinical Trials,Neurosciences,Research & Development

    Scottish Brain Sciences opens new Alzheimer’s clinical research centre at ONE BioHub

    Scottish Brain Sciences (SBS), a clinical research organisation focused on [...]

    November 17, 2025
  • Neurosciences,Rare Diseases,Research & Development

    Successful treatment for ALS could deliver billions in global value

    New research commissioned by Challenge Works and conducted by the [...]

    November 13, 2025
  • Biotech,Central Nervous System,Clinical Development,Neurosciences,Partnerships & Funding,Research & Development

    Modulight Biotherapeutics raises $12 million seed funding for optogenetic therapy development

    Modulight Biotherapeutics has raised $12.2 million in a Seed funding [...]

    November 13, 2025
  • Central Nervous System,Clinical studies,Digital Health,Mental health,Neurosciences

    At-home brain stimulation therapy helps prevent depression relapse, study finds

    A major international study has found that remotely supervised, at-home [...]

    November 12, 2025
  • Biotech,Clinical Development,Drug Development,Events and Conferences,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    November 10, 2025
  • Cell & Gene Therapy,Genomics and sequencing,Neurosciences,Research & Development,Technology and platforms

    Atomic ‘Hook’ in motor protein unlocks neuron cargo delivery secrets

    A team from the University of Tokyo and Juntendo University [...]

    November 6, 2025
  • Clinical Trials,Digital Health,Mental health,Neurosciences

    Digital therapeutic cuts schizophrenia’s negative symptoms in trial

    Boehringer Ingelheim and Click Therapeutics have reported Phase 3 results [...]

    October 13, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme
    Categories: Central Nervous System, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
  • Horiba UK launches philanthropic foundation to advance scientific research and broaden STEM participation
    Categories: Facilities and infrastructure, Healthcare leadership, Research & Development
  • Net-zero in action: ABB powers GSK’s sustainability leap in Singapore
    Categories: CDMOs & Manufacturing, Market Access & Commercialization, Sustainability
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top